May 19th, 2020
STELLA PHARMA will launch Steboronine®, the World’s First BNCT Drug, on May 20, 2020
STELLA PHARMA CORPORATION (Head office: Chuoku, Osaka City; President: Tomoyuki……
Press Release
March 25th, 2020
STELLA PHARMA Receives Marketing and Manufacturing Approval in Japan for “Steboronine® Intravenous Drip Bag 9000mg/300mL
STELLA PHARMA CORPORATION (Head office: Chuo-ku, Osaka City, President: Tomoyuk……
January 23rd, 2020
How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment
Boron neutron capture therapy (BNCT) is a technique in which p‐boronophenylalan……
November 7th, 2019
“Commencement of Clinical Trial of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma and Angiosarcoma” issued
Cancer Intelligence Care Systems, Inc. (“CICS;” President: Tetsuya Furukawa; he……
October 15th, 2019
STELLA PHARMA CORPORATION has recently filed for approval to manufacture and sell a boron agent for BNCT
STELLA PHARMA CORPORATION (Head office: Chuo-ku, Osaka City; President: Tomoyuk……
